[一种新型抗过敏药物（BM 06.001）对特应性犬类过敏反应的抑制作用（作者译）]
[Inhibition of anaphylactic reactions in atopic dogs by means of a new antiallergic drug (BM 06.001) (author's transl)].
作者信息
Zimmermann I, Ulmer W T, Roesch A
出版信息
Arzneimittelforschung. 1977;27(10):1999-2002.
PMID:579112
Abstract
The antiallergic action of an orally administered piperazinopropyl-adenine (BM 06.001) was demonstrated in atopic dogs. It was shown that the substance was able to inhibit both the skin reactions and the bronchial obstruction caused by ascaris antigen at approximately the same dosage.
摘要
口服哌嗪丙基腺嘌呤（BM 06.001）在特应性犬中显示出抗过敏作用。结果表明，该物质能够以大致相同的剂量抑制由蛔虫抗原引起的皮肤反应和支气管阻塞。
Zotero 插件